pamidronate disodium
Sponsors
Hokkaido University, City of Hope Medical Center, Hackensack Meridian Health, National Cancer Institute (NCI), The Hospital for Sick Children
Conditions
Breast CancerDiffuse Sclerosing Osteomyelitis of the jawFemoral Head Avascular NecrosisMultiple Myeloma and Plasma Cell NeoplasmRefractory Multiple MyelomaSAPHO SyndromeUnspecified Adult Solid Tumor, Protocol Specific
Phase 1
Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma
CompletedNCT00124605
Start: 2005-04-30Updated: 2013-01-07
Efficacy of Bisphosphonates in Patients With Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome
CompletedNCT02544659
Start: 2015-10-31End: 2016-10-31Updated: 2016-10-13
Phase 2
Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma
CompletedNCT00004088
Start: 1999-04-13End: 2018-01-09Updated: 2019-07-02
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
CompletedNCT00004906
Start: 1999-10-31End: 2001-06-30Updated: 2013-05-30
Phase 3
Unknown Phase
The Use of Bisphosphonates in the Treatment of Avascular Necrosis of the Femoral Head
TerminatedNCT02007915
Start: 2009-07-31End: 2013-06-30Updated: 2017-10-13
Evaluation of Usefulness of Bisphosphanate for diffuse sclerosing osteomyelitis of the jaw
RecruitingJPRN-UMIN000032089
Start: 2018-04-22Target: 13Updated: 2026-06-29